Grant Lawson 4/7/25 Grant Lawson 4/7/25 Kent Lake Comments on Quanterix’s Value Destructive Bridge Financing for Financially Troubled Akoya BUSINESSWIRE Read More Grant Lawson 3/31/25 Grant Lawson 3/31/25 SCHEDULE 14A Preliminary Proxy SEC Read More Grant Lawson 3/17/25 Grant Lawson 3/17/25 Kent Lake Urges Quanterix Management to Address Key Questions Regarding its Proposed Transaction with Akoya Biosciences During Today’s Earnings Call BUSINESSWIRE Read More Grant Lawson 3/11/25 Grant Lawson 3/11/25 Kent Lake Issues Investor Presentation Detailing Opposition to Quanterix’s Proposed Merger with Akoya Biosciences BUSINESSWIRE Read More Grant Lawson 3/3/25 Grant Lawson 3/3/25 Kent Lake Nominates Three Highly Qualified, Independent Candidates for Quanterix Board BUSINESSWIRE Read More Grant Lawson 2/18/25 Grant Lawson 2/18/25 Kent Lake Issues Letter to Quanterix Shareholders Regarding Opposition to the Company’s Proposed Merger with Akoya Biosciences BUSINESSWIRE Read More Grant Lawson 2/7/25 Grant Lawson 2/7/25 SCHEDULE 13D SEC Read More
Grant Lawson 4/7/25 Grant Lawson 4/7/25 Kent Lake Comments on Quanterix’s Value Destructive Bridge Financing for Financially Troubled Akoya BUSINESSWIRE Read More
Grant Lawson 3/17/25 Grant Lawson 3/17/25 Kent Lake Urges Quanterix Management to Address Key Questions Regarding its Proposed Transaction with Akoya Biosciences During Today’s Earnings Call BUSINESSWIRE Read More
Grant Lawson 3/11/25 Grant Lawson 3/11/25 Kent Lake Issues Investor Presentation Detailing Opposition to Quanterix’s Proposed Merger with Akoya Biosciences BUSINESSWIRE Read More
Grant Lawson 3/3/25 Grant Lawson 3/3/25 Kent Lake Nominates Three Highly Qualified, Independent Candidates for Quanterix Board BUSINESSWIRE Read More
Grant Lawson 2/18/25 Grant Lawson 2/18/25 Kent Lake Issues Letter to Quanterix Shareholders Regarding Opposition to the Company’s Proposed Merger with Akoya Biosciences BUSINESSWIRE Read More
